Sign in
Not yet recruitingPhase 4

Intravenous Dexamethasone for ESP Block Analgesia in Children Undergoing Idiopathic Scoliosis Surgery

Key facts

Who runs it
Poznan University of Medical Sciences
Where
Poland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
Phase
Phase 4
People taking part
90 people, planned
Started
1 Nov 2026
Expected to end
1 Jan 2028
Type of study
Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Dexamethasone (0.1 mg/kg)
  • Dexamethasone (0.2 mg/kg)
  • Placebo
Record updated
22 October 2026

Who can take part

Age
10 years to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Age 10 to 18 years
  • Diagnosis of idiopathic scoliosis
  • Scheduled for elective surgical correction of scoliosis under general anesthesia with bilateral ultrasound-guided erector spinae plane (ESP) blocks
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Written informed consent provided by a parent or legal guardian
  • Participant assent obtained when developmentally appropriate and in accordance with applicable ethical requirements

Who cannot take part

  • Systemic corticosteroid therapy before surgery that, in the investigator's judgment, could affect study outcomes
  • Chronic opioid therapy before surgery
  • Chronic pain requiring regular analgesic medication
  • Previous adverse reaction or clinically significant intolerance to fentanyl
  • Known allergy or hypersensitivity to dexamethasone, local anesthetics, fentanyl, or other medications used in the study protocol
  • Contraindication to ESP block, including infection at the planned injection site or clinically significant coagulation disorder
  • Severe hepatic or renal impairment
  • Any medical condition that, in the investigator's judgment, could interfere with study procedures, assessment of outcomes, or participant safety
  • Diabetes mellitus or another clinically significant disorder of glucose metabolism
  • Participation in another interventional clinical trial that could affect the study outcomes

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 10 and 18 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This randomized, double-blind, placebo-controlled study will evaluate the effect of intravenous dexamethasone on postoperative analgesia in children and adolescents undergoing surgery for idiopathic scoliosis with bilateral erector spinae plane (ESP) blocks.

Read full original descriptionShow less

Participants will be randomly assigned in a 1:1:1 ratio to receive intravenous placebo, dexamethasone 0.1 mg/kg, or dexamethasone 0.2 mg/kg. All participants will receive standardized general anesthesia, bilateral ultrasound-guided ESP blocks, and multimodal postoperative analgesia.

The study will evaluate postoperative opioid requirements and the duration and quality of postoperative analgesia. Secondary outcomes will include postoperative pain intensity, time to first rescue opioid administration, the proportion of participants requiring rescue opioid analgesia, postoperative nausea and vomiting, blood glucose concentrations, and adverse events.

The study aims to determine whether intravenous dexamethasone improves postoperative analgesia following ESP block and whether the analgesic effect differs between the two studied dexamethasone doses.

The 3 groups in the trial

  • PlaceboPlacebo, for comparison

    Participants will receive intravenous placebo (0.9% sodium chloride) in addition to standardized general anesthesia, bilateral ultrasound-guided erector spinae plane (ESP) blocks, and standardized multimodal postoperative analgesia.

  • Dexamethasone 0.1 mg/kgTreatment being tested

    Participants will receive intravenous dexamethasone 0.1 mg/kg, with a maximum dose of 4 mg, in addition to standardized general anesthesia, bilateral ultrasound-guided erector spinae plane (ESP) blocks, and standardized multimodal postoperative analgesia.

  • Dexamethasone 0.2 mg/kgTreatment being tested

    Participants will receive intravenous dexamethasone 0.2 mg/kg, with a maximum dose of 8 mg, in addition to standardized general anesthesia, bilateral ultrasound-guided erector spinae plane (ESP) blocks, and standardized multimodal postoperative analgesia.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of Two Doses of Intravenous Dexamethasone on Postoperative Analgesia After Erector Spinae Plane Block in Children Undergoing Surgery for Idiopathic Scoliosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Criteria questions
Built from NCT07890220, who can take part
Record updated
22 October 2026